FGFBP2 anticorps (AA 121-220) (Biotin)

N° du produit ABIN1390357

Détail du produit anti-FGFBP2 anticorps (Biotin)

Antigène: FGFBP2 (Fibroblast Growth Factor Binding Protein 2 (FGFBP2))

Épitope: AA 121-220

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FGFBP2 est conjugé à/à la Biotin

Application: ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Réactivité croisée: Humain

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human FGFBP2/KSP37

Isotype: IgG

Information d'application

Indications d'application: IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur FGFBP2

Antigène: FGFBP2 (Fibroblast Growth Factor Binding Protein 2 (FGFBP2))

Autre désignation: FGFBP2/KSP37 (FGFBP2 Produits)

Synonymes: anticorps fb08g06, anticorps wu:fb08g06, anticorps HBP17RP, anticorps KSP37, anticorps fibroblast growth factor binding protein 2, anticorps fibroblast growth factor binding protein 2a, anticorps fibroblast growth factor binding protein 2 L homeolog, anticorps FGFBP2, anticorps fgfbp2a, anticorps fgfbp2.L

Sujet:

Synonyms: FGF-binding protein 2, FGF-BP2, FGFBP-2, FGFBP2, FGFP2_HUMAN, Fibroblast growth factor-binding protein 2, HBp17-related protein, HBp17-RP, Ksp37, 37 kDa killer-specic secretory protein.

Background: KSP37 is a 223 amino acid protein that is secreted into the extracellular space and belongs to the fibroblast growth factor-binding protein family. Expressed in serum, as well as in cytotoxic T lymphocytes and peripheral leukocytes, KSP37 is thought to be involved in lymphocyte-mediated immunity, possibly playing a role in the development of asthma. The gene encoding KSP37 maps to human chromosome 4, which encodes nearly 6 % of the human genome and has the largest gene deserts (regions of the genome with no protein encoding genes) of all of the human chromosomes. Defects in some of the genes located on chromosome 4 are associated with Huntington's disease, Ellis-van Creveld syndrome, methylmalonic acidemia and polycystic kidney disease.